These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38346093)

  • 1. RETINAL VEIN OCCLUSIONS BEFORE AND DURING THE COVID-19 PANDEMIC: Visual Outcomes and Treatment Patterns in a Country with no Mandatory Lockdown.
    Cullhed Farrell A; Epstein D
    Retina; 2024 Jun; 44(6):1045-1051. PubMed ID: 38346093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Outcomes of Ranibizumab Treatment in French Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion: 24-Month Results from the BOREAL-RVO Study.
    Glacet-Bernard A; Girmens JF; Kodjikian L; Delcourt C; Fajnkuchen F; Creuzot-Garcher C; San Nicolas N; Massin P
    Ophthalmic Res; 2023; 66(1):824-834. PubMed ID: 36972579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion.
    de Salles MC; Epstein D
    Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2653-2660. PubMed ID: 33738625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z; Mahroo O; Bunce C; Mitry D
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular dynamics and visual acuity prognosis in retinal vein occlusions - ways to connect.
    Dărăbuș DM; Pac CP; Roşca C; Munteanu M
    Rom J Ophthalmol; 2023; 67(3):312-324. PubMed ID: 37876516
    [No Abstract]   [Full Text] [Related]  

  • 6. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term real-world outcomes in retinal vein occlusions: How close are we to the trials?
    Shah PN; Shanmugam MP; Vora UB; Agrawal S; Sirivella I; Suryakanth S; Jayasingh R
    Indian J Ophthalmol; 2022 Dec; 70(12):4370-4375. PubMed ID: 36453347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in Retinal Vein Occlusions Presenting with Poor Visual Acuity Treated with Anti-Vascular Endothelial Growth Factor Therapy: Prognosis and Predictive Factors.
    Light JG; Tian J; Wenick AS
    Ophthalmol Retina; 2021 Sep; 5(9):888-900. PubMed ID: 33227561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two-Year Follow-up Results of Patients with Macular Oedema Due to Retinal Vein Occlusion Treated with Ranibizumab].
    Hladíková Z; Klofáčová E; Kalvodová B
    Cesk Slov Oftalmol; 2017; 73(2):43-51. PubMed ID: 28931295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study.
    Campochiaro PA; Sophie R; Pearlman J; Brown DM; Boyer DS; Heier JS; Marcus DM; Feiner L; Patel A;
    Ophthalmology; 2014 Jan; 121(1):209-219. PubMed ID: 24112944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study.
    Callizo J; Ziemssen F; Bertelmann T; Feltgen N; Vögeler J; Koch M; Eter N; Liakopoulos S; Schmitz-Valckenberg S; Spital G
    Clin Ophthalmol; 2019; 13():2167-2179. PubMed ID: 31806930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
    Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
    Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
    Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications.
    Papadia M; Misteli M; Jeannin B; Herbort CP
    Int Ophthalmol; 2014 Dec; 34(6):1193-201. PubMed ID: 25245600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
    Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
    [No Abstract]   [Full Text] [Related]  

  • 18. Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular Edema.
    Iftikhar M; Mir TA; Hafiz G; Zimmer-Galler I; Scott AW; Solomon SD; Sodhi A; Wenick AS; Meyerle C; Jiramongkolchai K; Liu TYA; Arevalo JF; Singh M; Kherani S; Handa JT; Campochiaro PA
    Am J Ophthalmol; 2019 Sep; 205():17-26. PubMed ID: 30954469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
    Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
    Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal Injection of Anti-Vascular Endothelial Growth Factors Combined with Corticosteroids for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis.
    Namvar E; Yasemi M; Nowroozzadeh MH; Ahmadieh H
    Semin Ophthalmol; 2024 Jan; 39(1):109-119. PubMed ID: 37621098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.